MOLN:NASDAQ
Molecular Partners AG
$4.21
arrow_upward
+7.40%(+0.29) 1D
Sep 18, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MOLN...
Open
$4.02
High
$4.72
Low
$4.02
Mkt. cap
170.76M
Avg. vol.
1.16K
Volume
2.86K
52-wk high
$5.36
52-wk low
$3.53
EPS
-$1.66
Beta
1.02
Shares outstanding
40.38M
No. of employees
134
Open
$4.02
High
$4.72
Low
$4.02
Mkt. cap
170.76M
Avg. vol.
1.16K
Volume
2.86K
52-wk high
$5.36
52-wk low
$3.53
EPS
-$1.66
Beta
1.02
Shares outstanding
40.38M
No. of employees
134
News stories
From web sources and news partners
https://www.dars.gov.et/
·
2 weeks ago
MOLN Q2 2026 Earnings: Reported Loss of -$0.35 per ADS, No Revenue, Shares Slip 3.28% - Surprise Factor Analysis
Profile
Molecular Partners AG is a clinical-stage biopharmaceutical company based in Zürich, Switzerland. The company is developing a new class of potent, specific and versatile small-protein therapies called DARPins, with potential clinical applications in a range of disease areas including oncology, immuno-oncology, ophthalmology, and infectious diseases. Molecular Partners currently has two DARPin molecules in clinical development, and a broad pipeline of molecules in preclinical development. Wikipedia
About Molecular Partners AG